Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

0QNV

Addex Therapeutics (0QNV)

Addex Therapeutics Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:0QNV
日付受信時刻ニュースソース見出しコード企業名
2025/01/0815 : 00UK RegulatoryAddex to Present at the 2025 Swiss Equities Baader ConferenceLSE:0QNVAddex Therapeutics Ltd
2024/11/2215 : 00UK RegulatoryAddex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
2024/11/1115 : 00UK RegulatoryAddex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024LSE:0QNVAddex Therapeutics Ltd
2024/09/3014 : 00UK RegulatoryAddex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
2024/09/1914 : 00UK RegulatoryAddex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net ProfitLSE:0QNVAddex Therapeutics Ltd
2024/09/0414 : 00UK RegulatoryAddex to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceLSE:0QNVAddex Therapeutics Ltd
2024/08/2714 : 00UK RegulatoryAddex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research CollaborationLSE:0QNVAddex Therapeutics Ltd
2024/07/2214 : 00UK RegulatoryAddex’s Partner Discontinues ADX71149 development in EpilepsyLSE:0QNVAddex Therapeutics Ltd
2024/07/1514 : 00UK RegulatoryAddex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)LSE:0QNVAddex Therapeutics Ltd
2024/07/1214 : 00UK RegulatoryAddex To Present at the Thirteenth London International Cough Symposium (13th LICS)LSE:0QNVAddex Therapeutics Ltd
2024/07/0114 : 00UK RegulatoryAddex Shareholders Approve All Resolutions at Annual General MeetingLSE:0QNVAddex Therapeutics Ltd
2024/06/0614 : 00UK RegulatoryAddex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
2024/06/0514 : 00UK RegulatoryAddex Convenes Annual General Meeting 2024LSE:0QNVAddex Therapeutics Ltd
2024/05/3114 : 00UK RegulatoryAddex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024LSE:0QNVAddex Therapeutics Ltd
2024/05/0814 : 00UK RegulatoryAddex to Present at Bio€quity Europe 2024LSE:0QNVAddex Therapeutics Ltd
2024/04/2914 : 00UK RegulatoryAddex Provides Update on ADX71149 Phase 2 Epilepsy StudyLSE:0QNVAddex Therapeutics Ltd
2024/04/1914 : 00UK RegulatoryAddex to Present at the Swiss Biotech Day 2024LSE:0QNVAddex Therapeutics Ltd
2024/04/1814 : 00UK RegulatoryAddex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateLSE:0QNVAddex Therapeutics Ltd
2024/04/1114 : 00UK RegulatoryAddex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024LSE:0QNVAddex Therapeutics Ltd
2024/04/0314 : 00UK RegulatoryAddex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersLSE:0QNVAddex Therapeutics Ltd
2024/03/1415 : 00UK RegulatoryAddex to Present at the Bio-Europe Spring 2024 ConferenceLSE:0QNVAddex Therapeutics Ltd
2024/01/3115 : 00UK RegulatoryAddex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.LSE:0QNVAddex Therapeutics Ltd
 Showing the most relevant articles for your search:LSE:0QNV

最近閲覧した銘柄

Delayed Upgrade Clock